|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Vardenatil demon started similar efficacy and tolerability among older and younger patients with marginal difference in PK characteristics between age groups 显示文摘 | Steidle C Porst H Hollister A | 2001 | Int J Impot Res2001，13，5： | 1 |
| 2 | The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience显示文摘 | | 1996 | J Urol1996，155，： | 1 |
| 3 | Premature ejaculation显示文摘 | Porst H | 2009 | Urologe A2009，48，6： | 1 |
| 4 | Fat-cell mass, serum leptin and adiponectin changes during weight gain and loss in yellow- bellied marmots ( Mannota flaviventris ) 显示文摘 | Florant GL Porst H Peiffer A | 2004 | J Comp Physiol2004，174，8： | 1 |
| 5 | Bulbocave mosus-reflex latencies and pudendal nerve SSEP compared to penile vascular testing in 669 patients with erectile failure and other sexual dysfunction显示文摘 | Fabra M Porst H | 1999 | Int J Impot Res1999，11，3： | 1 |
| 6 | Tadalafil allows men with erectile dysfunction to have successful intercourse up to 36 hours postdose显示文摘 | Porst H Rosen RC Padma-Nathan H | | J Uro10，167，4： | 1 |
| 7 | Relevance of dynamic cavernosography to the diagnosis of venous incompetence in erectile dysfunction显示文摘 | Porst H Ahlen HV Vaahlensieck W | 1987 | J Urol1987，137，： | 1 |
| 8 | A randomised,placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia显示文摘 | Stief CG Porst H Neuser D | 2008 | Eur Urol2008，53，6： | 1 |
| 9 | IC351(tadalafil, Cialis):update on clinical experience显示文摘 | Porst H | 2002 | Int J Impot Res2002，14，1： | 1 |
| 10 | IC351(tadalafil,Cialis):update on clinical experience显示文摘 | Porst H | 2002 | Int J Impot Res2002，14，1： | 1 |
| 11 | Development and validation of the quality of erection questionnaire显示文摘 | PORST H GILBERT C COLLINS S | 2007 | J Sex Med2007，4，： | 1 |
| 12 | The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbi- dities, and professional help-seeking 显示文摘 | Porst H Montorsi F Rosen RC | 2007 | Eur Urol2007，51，3： | 1 |
| 13 | Comparing vardenatil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease:a randomized,doubleblind,pooled crossover study显示文摘 | Rubio-Aurioles Porst H Eardley I | 2006 | J Sex Med2006，3，6： | 1 |
| 14 | Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing:A randomized controlled trial显示文摘 | Porst H Padma-Nathan H Giuliano F | | 0，，1： | 1 |
| 15 | A Randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia 显示文摘 | STIEF C G PORST H NEUSER D | 2008 | Eur Urol2008，53，6： | 1 |
| 16 | Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies显示文摘 | PORST H OELKE M GOLDFISCHER ER | 2013 | Urology2013，82，3： | 1 |
| 17 | Sustained efficacy and tolerability with vardenafil over 2 years of treatment in men with erecitle dysfunction显示文摘 | Stief C Porst H Saenz de Tejada Ⅰ | 2004 | Int J Clin Pract2004，58，3： | 1 |
| 18 | The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first athome clinical trail显示文摘 | Porst H RosenR Padma-NathanH etal | 2001 | Int J Impot Res2001，13，4： | 1 |
| 19 | Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent international society for sexual medicine criteria for lifelong prema- ture ejaculatlon显示文摘 | McMahon CG Porst H | 2011 | Sex Med2011，8，10： | 1 |
| 20 | Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups显示文摘 | Porst H Young JM Schmidt AC | 2003 | Urology2003，62，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员